Reply

Affiliations

¹ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA. Electronic address: david.shalowitz@uphs.upenn.edu.
² Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX.
³ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA.

Comment

David I Shalowitz et al. Am J Obstet Gynecol. 2016 Dec.

. 2016 Dec;215(6):811.

doi: 10.1016/j.ajog.2016.07.054. Epub 2016 Aug 2.

¹ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA. Electronic address: david.shalowitz@uphs.upenn.edu.
² Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX.
³ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA.

No abstract available

Comment on

Interactions with industry under the Sunshine Act: an example from gynecologic oncology.
Shalowitz DI, Spillman MA, Morgan MA. Shalowitz DI, et al. Am J Obstet Gynecol. 2016 Jun;214(6):703-7. doi: 10.1016/j.ajog.2016.02.035. Epub 2016 Feb 20. Am J Obstet Gynecol. 2016. PMID: 26902988
The Physician Payments Sunshine Act: a smokescreen if no action!
Braillon A, Bewley S. Braillon A, et al. Am J Obstet Gynecol. 2016 Dec;215(6):810-811. doi: 10.1016/j.ajog.2016.07.053. Epub 2016 Aug 2. Am J Obstet Gynecol. 2016. PMID: 27496686 No abstract available.